Mrs. Eileen Hamele, MS,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6602 Jacobs Way, Madison, WI 53711 Phone: 608-273-4362 |
Kelsey Glavee, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 128 E Olin Ave Ste 100, Madison, WI 53713 Phone: 608-204-6242 Fax: 608-252-1333 |
Jordynn Elizabeth Koroschetz, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2111 University Ave Apt 3, Madison, WI 53726 Phone: 000-000-0000 |
Jocelyn Jenks Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8060 Fax: 608-262-7679 |
Braeden Yeo, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3113 W Beltline Hwy Ste 300, Madison, WI 53713 Phone: 608-819-6810 Fax: 608-819-6811 |
Claire Bledsoe Quisling Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Compliance Mail Code 2433, Madison, WI 53792 Phone: 608-662-0817 |
Laura M Lenzen, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1414 S Park St, Madison, WI 53715 Phone: 608-417-8250 |
Ms. Kellie Marie Haugen, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1500 Highland Ave, Room 329, Madison, WI 53705 Phone: 608-263-3301 Fax: 608-265-7429 |
Ms. Debra Jean Rheinsmith, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5806 Bartlett Ln, Madison, WI 53711 Phone: 608-617-4109 |
Erica Ann Mishek, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-8250 Fax: 608-417-5315 |
Mrs. Marie Anne-elizabeth Hendrickson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Aud/speech, Madison, WI 53705 Phone: 608-256-1901 |
Georgia A Malandraki, PHD, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6190 |
Katherine Garnier Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-7546 |
Emily Hyypio, MS Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: University Of Wisconsin Hospital And Clinics, 600 Highland Avenue, Madison, WI 53792 Phone: 608-263-8060 Fax: 608-262-7679 |
Jessica Mae Ludwig Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Highland Ave, Madison, WI 53705 Phone: 608-263-2522 |
Sherri K Zelazny, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8437 Fax: 608-263-6199 |
Julie A Raetz-beckman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Compliance Mc 2433, Madison, WI 53792 Phone: 608-662-0817 |
Karly Curtin Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-6000 |
Brittany Macrander Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 Deming Way, Madison, WI 53717 Phone: 608-819-6394 |
On The Grow Speech Therapy, S.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6720 Fairhaven Rd Apt 11, Madison, WI 53719 Phone: 515-291-6313 |
News Archive
Syne qua non (SQN), today announced a significant enhancement to their EDC and Clinical Trial Management System, Syne-clin.
Students from rural communities who want to attend college face challenges on their pathways to higher education, according to a new study from a University of Georgia researcher.
Sepsis, a form of systemic inflammation, is the leading cause of death in critically ill patients. Sepsis is linked with massive cell death; however, the specific mechanisms involved in the lethality of sepsis are unclear. Now, a new study published by Cell Press in the December 23rd issue of the journal Immunity finds that inhibition of a specific cell death pathway called "necroptosis" protected mice from lethal inflammation.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
› Verified 4 days ago